Cartilage Endplate‐Targeted Engineered Exosome Releasing and Acid Neutralizing Hydrogel Reverses Intervertebral Disc Degeneration

Jiawen Zhan,Yongzhi Cui,Ping Zhang,Yuxuan Du,Prisca Hecker,Shuaiqi Zhou,Yupeng Liang,Weiye Zhang,Zhefeng Jin,Yuan Wang,Weihang Gao,Oleksandr Moroz,Liguo Zhu,Xiaoguang Zhang,Ke Zhao

DOI: https://doi.org/10.1002/adhm.202403315

IF: 10

2024-11-26

Advanced Healthcare Materials

Abstract:CAP‐sEXOs@Gel slowly releases encapsulated exosomes, inhibits iron ion influx and mtDNA‐cGAS‐STING pathway, ultimately alleviating the inflammation in CEPCs. The suppression of inflammation and subsequent secretory phenotype conversion indirectly alleviate NPCs senescence. Furthermore, the composite hydrogel directly alleviates NPC inflammaging by neutralizing excess H+ in the intervertebral disc microenvironment through its CaCO3 component. Cartilage endplate cell (CEPC) and nucleus pulposus cell (NPC) inflammation are critical factors that contribute to intervertebral disc degeneration (IVDD). Recent evidence indicated that iron ion influx, reactive oxygen species (ROS), and the cGAS‐STING pathway are involved in CEPC inflammatory degeneration. Moreover, cytokines produced by degenerating CEPCs and lactic acid accumulation within the microenvironment significantly contribute to NPC inflammation. Consequently, simultaneous alleviation of CEPC inflammation and correction of the acidic microenvironment are anticipated to reverse IVDD. Herein, CEPC‐targeted engineered exosomes loaded with salvianolic acid A are incorporated into a CaCO3/chitosan hydrogel, forming a composite gel, CAP‐sEXOs@Gel. Notably, CAP‐sEXOs@Gel shows long local retention, realizes the slow release of CAP‐sEXOs and specific uptake by CEPCs. After uptake by CEPCs, CAP‐sEXOs reduce intracellular iron ion and ROS by inhibiting hypoxia‐inducible factor‐2α (HIF‐2α)/TfR1 expression. Iron ion influx and ROS inhibition contribute to the maintenance of normal mitochondrial function and reduced mtDNA leakage, suppresing the cGAS‐STING pathway. Additionally, the CaCO3 component of CAP‐sEXOs@Gel neutralizes H+, thereby alleviating NPC inflammation. Collectively, this novel composite hydrogel demonstrates the ability to concurrently inhibit CEPC and NPC inflammation, thereby presenting a promising therapeutic approach for IVDD.

nanoscience & nanotechnology,engineering, biomedical,materials science, biomaterials